6. Glycemic Targets: Standards of Medical Care in Diabetes-2021.

@article{20216GT,
  title={6. Glycemic Targets: Standards of Medical Care in Diabetes-2021.},
  author={},
  journal={Diabetes care},
  year={2021},
  volume={44 Suppl 1},
  pages={
          S73-S84
        }
}
  • Published 1 January 2021
  • Medicine
  • Diabetes care
The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc21-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted… 
View on PubMed
care.diabetesjournals.org
218 Citations
Highly Influential Citations
2
Background Citations
5
Methods Citations
1

Figures and Tables from this paper

218 Citations

Citation Type

Citation Type

American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus.
  • G. Grunberger, J. Sherr, J. Unger
  • Medicine
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
  • 2021
Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes
TLDR
A person-centered approach to diabetes management is achieved through shared decision making, integration of evidence-based care and patient´s needs, values and preferences, and minimally disruptive approaches to diabetes care and at the same time offer practical guidance to clinicians and patients.
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations
TLDR
The use of a personalized approach in the management of people with T2D can reduce the cost and failure associated with the algorithmic “one-size-fits-all” approach, to anticipate disease progression, improve the response to diabetes pharmacotherapy and reduce the incidence of diabetes-associated complications.
The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
Utilizing point-of-care A1c to impact outcomes – can we make it happen in primary care?
TLDR
POC A1c testing in primary care, if widely available and integrated into workflow, has the potential to positively impact diabetes care and real-time feedback may change patient and physician behaviors, allowing earlier therapeutic intensification.
Alphabet strategy for diabetes care: A checklist approach in the time of COVID-19 and beyond
TLDR
The Alphabet strategy for diabetes care has facilitated evidence-based, cost-efficient multifactorial intervention with an improvement in the National Diabetes Audit targets for blood pressure, cholesterol levels and glycated haemoglobin.
Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept
TLDR
The calculated ‘YoDa’ (Years of Drug administration) is proposed as an easily comparable metric between the drug accrual cost and clinical outcomes and a series of steps or ‘deliberations’, which a clinician should consider in making a final choice of sodium-glucose co-transporter-2 inhibitor therapy.
Diagnosis and management of pediatric type 1 diabetes mellitus
TLDR
Effective cooperation and coordination between patient, parents, and healthcare providers are necessary to achieve a successful transition from pediatric to adult care in patients with T1DM.
Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
TLDR
The objective of this review was to assess the various national and international guidelines on diabetes management and understand the recommendations specific to SUs in various scenarios and suggest the use of certain second-generation SUs as second-line therapy or in combination with other AHAs in select population and specific scenarios.
Diabetes Care in India: A Descriptive Study
TLDR
Most doctors, qualified as well as nonqualified, did not follow the standard guidelines for diagnosis, treatment, and patient education regarding T2DM; therefore, it is necessary to train all medical practitioners regarding these guidelines.
...
...

References

SHOWING 1-10 OF 138 REFERENCES
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
TLDR
A panel to update the prior position statements on the management of type 2 diabetes in adults includes additional focus on lifestyle management and diabetes self-management education and support and efforts targeting weight loss.
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
TLDR
This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
TLDR
The scope and priorities of the American Diabetes Association’s 3-year Overcoming Therapeutic Inertia Initiative include publishing a systematic review and meta-analysis of approaches to reducing therapeutic inertia, developing a registry of effective strategies, and potentially executing pragmatic research to test promising interventions.
Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care
TLDR
This paper describes the consensus recommendations from a group of German expert diabetologists on the necessary steps for assessing an AGP in a structured and detailed way and explains these steps using practical clinical examples.
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
TLDR
The evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews by the American Diabetes Association and The Endocrine Society is reviewed to provide guidance about how this new information should be incorporated into clinical practice.
Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.
TLDR
Hb A(1c) is now recommended for diagnosing diabetes, further accentuating the need for optimal assay performance and limiting the ability of clinicians to use these targets.
Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial
Standardizing Clinically Meaningful Outcome Measures Beyond HbA 1 c for Type 1 Diabetes : A Consensus Report of the American Association of Clinical Endocrinologists
To identify and define clinically meaningful type 1 diabetes outcomes beyond hemoglobin A1c (HbA1c) based upon a review of the evidence, consensus from clinical experts, and input from researchers,…
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
TLDR
Examination of glycemic control levels among older adults with diabetes mellitus by health status and the prevalence of potential overtreatment of diabetes suggests the harms of intensive treatment likely exceed the benefits for older patients with complex/intermediate or very complex/poor health.
Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
TLDR
A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control, and these results support an additional management method that may benefit patients.
...
...